North America Biopsy Procedures Outlook to 2023

Published : Jul-2017

No. of Pages : 114

order by fax Inquire before Buying request discount

Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5

2 Introduction 7
2.1 What Is This Report About? 7
2.2 Biopsy Procedures, Segmentation 7
2.3 Definitions of Procedures Covered in the Report 8

3 Biopsy Procedures, North America 10
3.1 Biopsy Procedures, North America, 2009-2023 10
3.2 Biopsy Procedures, North America, Category Comparison by Procedures, 2009-2023 12
3.3 Biopsy Procedures, North America, 2009-2016 14
3.4 Biopsy Procedures, North America, 2016-2023 16

4 Biopsy Procedures, Canada 18
4.1 Biopsy Procedures, Canada, 2009-2016 18
4.2 Biopsy Procedures, Canada, 2016-2023 20
4.2.1 Breast Biopsy Procedures, Canada, 2009-2016 22
4.2.2 Colorectal Biopsy Procedures, Canada, 2009-2016 24
4.2.3 Leukemia Biopsy Procedures, Canada, 2009-2016 26
4.2.4 Liver Biopsy Procedures, Canada, 2009-2016 27
4.2.5 Lung Biopsy Procedures, Canada, 2009-2016 29
4.2.6 Other Indications Biopsy Procedures, Canada, 2009-2016 30
4.2.7 Prostate Biopsy Procedures, Canada, 2009-2016 32
4.2.8 Thyroid Biopsy Procedures, Canada, 2009-2016 34
4.2.9 Breast Biopsy Procedures, Canada, 2016-2023 35
4.2.10 Colorectal Biopsy Procedures, Canada, 2016-2023 37
4.2.11 Leukemia Biopsy Procedures, Canada, 2016-2023 39
4.2.12 Liver Biopsy Procedures, Canada, 2016-2023 40
4.2.13 Lung Biopsy Procedures, Canada, 2016-2023 42
4.2.14 Other Indications Biopsy Procedures, Canada, 2016-2023 43
4.2.15 Prostate Biopsy Procedures, Canada, 2016-2023 45
4.2.16 Thyroid Biopsy Procedures, Canada, 2016-2023 47

5 Biopsy Procedures, Mexico 48
5.1 Biopsy Procedures, Mexico, 2009-2016 48
5.2 Biopsy Procedures, Mexico, 2016-2023 50
5.2.1 Breast Biopsy Procedures, Mexico, 2009-2016 52
5.2.2 Colorectal Biopsy Procedures, Mexico, 2009-2016 54
5.2.3 Leukemia Biopsy Procedures, Mexico, 2009-2016 56
5.2.4 Liver Biopsy Procedures, Mexico, 2009-2016 57
5.2.5 Lung Biopsy Procedures, Mexico, 2009-2016 59
5.2.6 Other Indications Biopsy Procedures, Mexico, 2009-2016 60
5.2.7 Prostate Biopsy Procedures, Mexico, 2009-2016 62
5.2.8 Thyroid Biopsy Procedures, Mexico, 2009-2016 64
5.2.9 Breast Biopsy Procedures, Mexico, 2016-2023 65
5.2.10 Colorectal Biopsy Procedures, Mexico, 2016-2023 67
5.2.11 Leukemia Biopsy Procedures, Mexico, 2016-2023 69
5.2.12 Liver Biopsy Procedures, Mexico, 2016-2023 70
5.2.13 Lung Biopsy Procedures, Mexico, 2016-2023 72
5.2.14 Other Indications Biopsy Procedures, Mexico, 2016-2023 73
5.2.15 Prostate Biopsy Procedures, Mexico, 2016-2023 75
5.2.16 Thyroid Biopsy Procedures, Mexico, 2016-2023 77

6 Biopsy Procedures, United States 78
6.1 Biopsy Procedures, United States, 2009-2016 78
6.2 Biopsy Procedures, United States, 2016-2023 80
6.2.1 Breast Biopsy Procedures, United States, 2009-2016 82
6.2.2 Colorectal Biopsy Procedures, United States, 2009-2016 84
6.2.3 Leukemia Biopsy Procedures, United States, 2009-2016 86
6.2.4 Liver Biopsy Procedures, United States, 2009-2016 87
6.2.5 Lung Biopsy Procedures, United States, 2009-2016 89
6.2.6 Other Indications Biopsy Procedures, United States, 2009-2016 90
6.2.7 Prostate Biopsy Procedures, United States, 2009-2016 92
6.2.8 Thyroid Biopsy Procedures, United States, 2009-2016 94
6.2.9 Breast Biopsy Procedures, United States, 2016-2023 95
6.2.10 Colorectal Biopsy Procedures, United States, 2016-2023 97
6.2.11 Leukemia Biopsy Procedures, United States, 2016-2023 99
6.2.12 Liver Biopsy Procedures, United States, 2016-2023 100
6.2.13 Lung Biopsy Procedures, United States, 2016-2023 102
6.2.14 Other Indications Biopsy Procedures, United States, 2016-2023 103
6.2.15 Prostate Biopsy Procedures, United States, 2016-2023 105
6.2.16 Thyroid Biopsy Procedures, United States, 2016-2023 107

7 Appendix 108
7.1 Research Methodology 109
7.1.1 Coverage 109
7.1.2 Secondary Research 109
7.1.3 Primary Research 110
7.1.4 Market Modeling and Forecasting 111
7.1.5 Company Share Analysis 112
7.1.6 Distribution Share Analysis 113
7.1.7 Benchmarking 113
7.2 GlobalData Consulting 113
7.3 Contact Us 114
7.4 Disclaimer 114

List of Tables

Table 1: Biopsy Procedures, North America, 2009-2023 11
Table 2: Biopsy Procedures, North America, Category Comparison by Procedures, 2009-2023 13
Table 3: Biopsy Procedures, North America, Historic, 2009-2016 15
Table 4: Biopsy Procedures, North America, Forecast, 2016-2023 17
Table 5: Biopsy Procedures, Canada, Historic, 2009-2016 19
Table 6: Biopsy Procedures, Canada, Forecast, 2016-2023 21
Table 7: Breast Biopsy Procedures, Canada, Historic, 2009-2016 23
Table 8: Colorectal Biopsy Procedures, Canada, Historic, 2009-2016 25
Table 9: Leukemia Biopsy Procedures, Canada, Historic, 2009-2016 26
Table 10: Liver Biopsy Procedures, Canada, Historic, 2009-2016 28
Table 11: Lung Biopsy Procedures, Canada, Historic, 2009-2016 29
Table 12: Other Indications Biopsy Procedures, Canada, Historic, 2009-2016 31
Table 13: Prostate Biopsy Procedures, Canada, Historic, 2009-2016 33
Table 14: Thyroid Biopsy Procedures, Canada, Historic, 2009-2016 34
Table 15: Breast Biopsy Procedures, Canada, Forecast, 2016-2023 36
Table 16: Colorectal Biopsy Procedures, Canada, Forecast, 2016-2023 38
Table 17: Leukemia Biopsy Procedures, Canada, Forecast, 2016-2023 39
Table 18: Liver Biopsy Procedures, Canada, Forecast, 2016-2023 41
Table 19: Lung Biopsy Procedures, Canada, Forecast, 2016-2023 42
Table 20: Other Indications Biopsy Procedures, Canada, Forecast, 2016-2023 44
Table 21: Prostate Biopsy Procedures, Canada, Forecast, 2016-2023 46
Table 22: Thyroid Biopsy Procedures, Canada, Forecast, 2016-2023 47
Table 23: Biopsy Procedures, Mexico, Historic, 2009-2016 49
Table 24: Biopsy Procedures, Mexico, Forecast, 2016-2023 51
Table 25: Breast Biopsy Procedures, Mexico, Historic, 2009-2016 53
Table 26: Colorectal Biopsy Procedures, Mexico, Historic, 2009-2016 55
Table 27: Leukemia Biopsy Procedures, Mexico, Historic, 2009-2016 56
Table 28: Liver Biopsy Procedures, Mexico, Historic, 2009-2016 58
Table 29: Lung Biopsy Procedures, Mexico, Historic, 2009-2016 59
Table 30: Other Indications Biopsy Procedures, Mexico, Historic, 2009-2016 61
Table 31: Prostate Biopsy Procedures, Mexico, Historic, 2009-2016 63
Table 32: Thyroid Biopsy Procedures, Mexico, Historic, 2009-2016 64
Table 33: Breast Biopsy Procedures, Mexico, Forecast, 2016-2023 66
Table 34: Colorectal Biopsy Procedures, Mexico, Forecast, 2016-2023 68
Table 35: Leukemia Biopsy Procedures, Mexico, Forecast, 2016-2023 69
Table 36: Liver Biopsy Procedures, Mexico, Forecast, 2016-2023 71
Table 37: Lung Biopsy Procedures, Mexico, Forecast, 2016-2023 72
Table 38: Other Indications Biopsy Procedures, Mexico, Forecast, 2016-2023 74
Table 39: Prostate Biopsy Procedures, Mexico, Forecast, 2016-2023 76
Table 40: Thyroid Biopsy Procedures, Mexico, Forecast, 2016-2023 77
Table 41: Biopsy Procedures, United States, Historic, 2009-2016 79
Table 42: Biopsy Procedures, United States, Forecast, 2016-2023 81
Table 43: Breast Biopsy Procedures, United States, Historic, 2009-2016 83
Table 44: Colorectal Biopsy Procedures, United States, Historic, 2009-2016 85
Table 45: Leukemia Biopsy Procedures, United States, Historic, 2009-2016 86
Table 46: Liver Biopsy Procedures, United States, Historic, 2009-2016 88
Table 47: Lung Biopsy Procedures, United States, Historic, 2009-2016 89
Table 48: Other Indications Biopsy Procedures, United States, Historic, 2009-2016 91
Table 49: Prostate Biopsy Procedures, United States, Historic, 2009-2016 93
Table 50: Thyroid Biopsy Procedures, United States, Historic, 2009-2016 94
Table 51: Breast Biopsy Procedures, United States, Forecast, 2016-2023 96
Table 52: Colorectal Biopsy Procedures, United States, Forecast, 2016-2023 98
Table 53: Leukemia Biopsy Procedures, United States, Forecast, 2016-2023 99
Table 54: Liver Biopsy Procedures, United States, Forecast, 2016-2023 101
Table 55: Lung Biopsy Procedures, United States, Forecast, 2016-2023 102
Table 56: Other Indications Biopsy Procedures, United States, Forecast, 2016-2023 104
Table 57: Prostate Biopsy Procedures, United States, Forecast, 2016-2023 106
Table 58: Thyroid Biopsy Procedures, United States, Forecast, 2016-2023 107
Table 59: Total Number of Primary Research Participants, General Surgery Market, by Country 111

List of Figures

Figure 1: Biopsy Procedures, North America, 2009-2023 10
Figure 2: Biopsy Procedures, North America, Category Comparison by Procedures, 2009-2023 12
Figure 3: Biopsy Procedures, North America, Historic, 2009-2016 14
Figure 4: Biopsy Procedures, North America, Forecast, 2016-2023 16
Figure 5: Biopsy Procedures, Canada, Historic, 2009-2016 18
Figure 6: Biopsy Procedures, Canada, Forecast, 2016-2023 20
Figure 7: Breast Biopsy Procedures, Canada, Historic, 2009-2016 22
Figure 8: Colorectal Biopsy Procedures, Canada, Historic, 2009-2016 24
Figure 9: Leukemia Biopsy Procedures, Canada, Historic, 2009-2016 26
Figure 10: Liver Biopsy Procedures, Canada, Historic, 2009-2016 27
Figure 11: Lung Biopsy Procedures, Canada, Historic, 2009-2016 29
Figure 12: Other Indications Biopsy Procedures, Canada, Historic, 2009-2016 30
Figure 13: Prostate Biopsy Procedures, Canada, Historic, 2009-2016 32
Figure 14: Thyroid Biopsy Procedures, Canada, Historic, 2009-2016 34
Figure 15: Breast Biopsy Procedures, Canada, Forecast, 2016-2023 35
Figure 16: Colorectal Biopsy Procedures, Canada, Forecast, 2016-2023 37
Figure 17: Leukemia Biopsy Procedures, Canada, Forecast, 2016-2023 39
Figure 18: Liver Biopsy Procedures, Canada, Forecast, 2016-2023 40
Figure 19: Lung Biopsy Procedures, Canada, Forecast, 2016-2023 42
Figure 20: Other Indications Biopsy Procedures, Canada, Forecast, 2016-2023 43
Figure 21: Prostate Biopsy Procedures, Canada, Forecast, 2016-2023 45
Figure 22: Thyroid Biopsy Procedures, Canada, Forecast, 2016-2023 47
Figure 23: Biopsy Procedures, Mexico, Historic, 2009-2016 48
Figure 24: Biopsy Procedures, Mexico, Forecast, 2016-2023 50
Figure 25: Breast Biopsy Procedures, Mexico, Historic, 2009-2016 52
Figure 26: Colorectal Biopsy Procedures, Mexico, Historic, 2009-2016 54
Figure 27: Leukemia Biopsy Procedures, Mexico, Historic, 2009-2016 56
Figure 28: Liver Biopsy Procedures, Mexico, Historic, 2009-2016 57
Figure 29: Lung Biopsy Procedures, Mexico, Historic, 2009-2016 59
Figure 30: Other Indications Biopsy Procedures, Mexico, Historic, 2009-2016 60
Figure 31: Prostate Biopsy Procedures, Mexico, Historic, 2009-2016 62
Figure 32: Thyroid Biopsy Procedures, Mexico, Historic, 2009-2016 64
Figure 33: Breast Biopsy Procedures, Mexico, Forecast, 2016-2023 65
Figure 34: Colorectal Biopsy Procedures, Mexico, Forecast, 2016-2023 67
Figure 35: Leukemia Biopsy Procedures, Mexico, Forecast, 2016-2023 69
Figure 36: Liver Biopsy Procedures, Mexico, Forecast, 2016-2023 70
Figure 37: Lung Biopsy Procedures, Mexico, Forecast, 2016-2023 72
Figure 38: Other Indications Biopsy Procedures, Mexico, Forecast, 2016-2023 73
Figure 39: Prostate Biopsy Procedures, Mexico, Forecast, 2016-2023 75
Figure 40: Thyroid Biopsy Procedures, Mexico, Forecast, 2016-2023 77
Figure 41: Biopsy Procedures, United States, Historic, 2009-2016 78
Figure 42: Biopsy Procedures, United States, Forecast, 2016-2023 80
Figure 43: Breast Biopsy Procedures, United States, Historic, 2009-2016 82
Figure 44: Colorectal Biopsy Procedures, United States, Historic, 2009-2016 84
Figure 45: Leukemia Biopsy Procedures, United States, Historic, 2009-2016 86
Figure 46: Liver Biopsy Procedures, United States, Historic, 2009-2016 87
Figure 47: Lung Biopsy Procedures, United States, Historic, 2009-2016 89
Figure 48: Other Indications Biopsy Procedures, United States, Historic, 2009-2016 90
Figure 49: Prostate Biopsy Procedures, United States, Historic, 2009-2016 92
Figure 50: Thyroid Biopsy Procedures, United States, Historic, 2009-2016 94
Figure 51: Breast Biopsy Procedures, United States, Forecast, 2016-2023 95
Figure 52: Colorectal Biopsy Procedures, United States, Forecast, 2016-2023 97
Figure 53: Leukemia Biopsy Procedures, United States, Forecast, 2016-2023 99
Figure 54: Liver Biopsy Procedures, United States, Forecast, 2016-2023 100
Figure 55: Lung Biopsy Procedures, United States, Forecast, 2016-2023 102
Figure 56: Other Indications Biopsy Procedures, United States, Forecast, 2016-2023 103
Figure 57: Prostate Biopsy Procedures, United States, Forecast, 2016-2023 105
Figure 58: Thyroid Biopsy Procedures, United States, Forecast, 2016-2023 107

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

North America Biopsy Procedures Outlook to 2023

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027